Stem Cell Therapy Reaches Critical Mass in Clinical Trials
Stem cell therapies have progressed from cautious optimism to over 100 clinical trials globally. The field now tackles Parkinson’s, diabetes, and epilepsy with promising early safety data. What challenges remain for widespread adoption?